← All companies

ELDN

Eledon Pharmaceuticals, Inc.

ELDN Nasdaq Pharmaceutical Preparations EDGAR ↗

$3.43

+0.05 +1.48%

Key statistics

from XBRL data in SEC filings

Market cap

$265M

Revenue (TTM)

$0.00

Net income (TTM)

-$78.1M

EPS (TTM)

$-0.77

P/E ratio

—

Dividend yield

—

Free cash flow

-$62.4M

Cash

$6.15M

Total assets

$147M

Gross margin

—

52-week range

$1.35 – $4.60

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Amended charter or bylaws; Shareholder vote results Jun 22, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Results of operations (earnings release) Mar 19, 2026 8-K Unregistered sale of equity Jan 2, 2026 8-K Results of operations (earnings release) Nov 14, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Entered a material agreement Nov 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 7, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-Q/A Quarter ended 2025-03-31 Aug 14, 2025 10-K/A Fiscal year ended 2024-12-31 Aug 14, 2025 8-K Results of operations (earnings release); Previously issued financials not reliable Aug 14, 2025 8-K Regulation FD disclosure Aug 6, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 12, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K/A Changed accountants Apr 14, 2025 8-K Changed accountants Apr 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Director or officer change Dec 20, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Entered a material agreement; Regulation FD disclosure Oct 30, 2024 8-K Regulation FD disclosure Oct 29, 2024 8-K Unregistered sale of equity Oct 1, 2024 8-K Entered a material agreement Sep 20, 2024 10-Q Quarter ended 2024-06-30 Aug 19, 2024 10-Q/A Quarter ended 2024-03-31 Aug 19, 2024 10-K/A Fiscal year ended 2023-12-31 Aug 19, 2024 8-K Results of operations (earnings release); Previously issued financials not reliable Aug 14, 2024 8-K Changed accountants Jul 12, 2024 8-K Unregistered sale of equity Jul 10, 2024 8-K Director or officer change; Shareholder vote results; Other events Jul 10, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Results of operations (earnings release) May 13, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure May 7, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 26, 2024